UNSPSC 51332518: Haloperidol decanoate

This classification denotes a butyrophenone with the molecular formula C31H41ClFNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AC20PJ4101, chemically known as 1-butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)- but more generally known as haloperidol decanoate, which bears US NIH Compound Identifier 3559. European Medicines Agency schedules Haloperidol decanoate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02452MIG.

UNSPSC 51332518 Haloperidol decanoate is a Commodity code designating a specific pharmaceutical product, but the recent state and local activity tagged under this code does not reflect procurement of haloperidol decanoate itself. Seminole County, Florida's posted opportunity (IFB 60459723LAS, due July 26, 2023) solicits naloxone and safe drug deactivation systems — opioid antagonists and harm-reduction equipment — rather than haloperidol decanoate, an antipsychotic medication used in mental health treatment. This mismatch suggests either a tagging error in the source data or a jurisdictional coding practice that does not align with the UNSPSC definition. The code shows no recent documented activity that reflects actual procurement of haloperidol decanoate at the state or local level.

The Seminole County solicitation, while posted under this code, represents community health and public safety procurement focused on opioid response rather than psychiatric medications. Without additional recent opportunities correctly tagged to haloperidol decanoate, the code does not present a clear signal of state and local buying patterns or geographic concentration for this specific pharmaceutical. Business development professionals should verify code assignment with procurement offices before pursuing opportunities tagged to this Commodity, as the current tagging does not align with the product scope.